701 related articles for article (PubMed ID: 14558079)
1. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.
Michaud K; Messer J; Choi HK; Wolfe F
Arthritis Rheum; 2003 Oct; 48(10):2750-62. PubMed ID: 14558079
[TBL] [Abstract][Full Text] [Related]
2. Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study.
Lajas C; Abasolo L; Bellajdel B; Hernández-García C; Carmona L; Vargas E; Lázaro P; Jover JA
Arthritis Rheum; 2003 Feb; 49(1):64-70. PubMed ID: 12579595
[TBL] [Abstract][Full Text] [Related]
3. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
[TBL] [Abstract][Full Text] [Related]
4. The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand.
Osiri M; Maetzel A; Tugwell P
J Rheumatol; 2007 Jan; 34(1):57-63. PubMed ID: 17183621
[TBL] [Abstract][Full Text] [Related]
5. An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline.
Yelin E; Wanke LA
Arthritis Rheum; 1999 Jun; 42(6):1209-18. PubMed ID: 10366114
[TBL] [Abstract][Full Text] [Related]
6. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia.
Wolfe F; Michaud K
J Rheumatol; 2004 Apr; 31(4):695-700. PubMed ID: 15088293
[TBL] [Abstract][Full Text] [Related]
7. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists?
Gabriel SE; Wagner JL; Zinsmeister AR; Scott CG; Luthra HS
Arthritis Rheum; 2001 Jul; 44(7):1504-14. PubMed ID: 11465700
[TBL] [Abstract][Full Text] [Related]
8. Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates.
Yelin E; Cisternas MG; Pasta DJ; Trupin L; Murphy L; Helmick CG
Arthritis Rheum; 2004 Jul; 50(7):2317-26. PubMed ID: 15248233
[TBL] [Abstract][Full Text] [Related]
9. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study.
Clarke AE; Zowall H; Levinton C; Assimakopoulos H; Sibley JT; Haga M; Shiroky J; Neville C; Lubeck DP; Grover SA; Esdaile JM
J Rheumatol; 1997 Jun; 24(6):1051-60. PubMed ID: 9195508
[TBL] [Abstract][Full Text] [Related]
10. Out-of-pocket expenses and their burden in patients with rheumatoid arthritis.
Wolfe F; Michaud K
Arthritis Rheum; 2009 Nov; 61(11):1563-70. PubMed ID: 19877107
[TBL] [Abstract][Full Text] [Related]
11. Modeling the lifetime costs of rheumatoid arthritis.
Gabriel SE; Crowson CS; Luthra HS; Wagner JL; O'Fallon WM
J Rheumatol; 1999 Jun; 26(6):1269-74. PubMed ID: 10381041
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project).
Hallert E; Husberg M; Jonsson D; Skogh T
Rheumatology (Oxford); 2004 Nov; 43(11):1374-82. PubMed ID: 15280570
[TBL] [Abstract][Full Text] [Related]
13. Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project).
Hallert E; Husberg M; Skogh T
Rheumatology (Oxford); 2006 Mar; 45(3):325-31. PubMed ID: 16287927
[TBL] [Abstract][Full Text] [Related]
14. The economic consequences of irritable bowel syndrome: a US employer perspective.
Leong SA; Barghout V; Birnbaum HG; Thibeault CE; Ben-Hamadi R; Frech F; Ofman JJ
Arch Intern Med; 2003 Apr; 163(8):929-35. PubMed ID: 12719202
[TBL] [Abstract][Full Text] [Related]
15. Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA.
Joyce AT; Smith P; Khandker R; Melin JM; Singh A
J Rheumatol; 2009 Apr; 36(4):743-52. PubMed ID: 19228658
[TBL] [Abstract][Full Text] [Related]
16. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
Merkesdal S; Ruof J; Huelsemann JL; Mittendorf T; Handelmann S; Mau W; Zeidler H
Arthritis Rheum; 2005 Apr; 53(2):234-40. PubMed ID: 15818718
[TBL] [Abstract][Full Text] [Related]
17. Determinants of direct costs in Dutch rheumatoid arthritis patients.
Verstappen SM; Verkleij H; Bijlsma JW; Buskens E; Kruize AA; Heurkens AH; Van Der Veen MJ; Jacobs JW
Ann Rheum Dis; 2004 Jul; 63(7):817-24. PubMed ID: 15194577
[TBL] [Abstract][Full Text] [Related]
18. The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis.
Ethgen O; Kahler KH; Kong SX; Reginster JY; Wolfe F
J Rheumatol; 2002 Jun; 29(6):1147-55. PubMed ID: 12064827
[TBL] [Abstract][Full Text] [Related]
19. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone.
Korthals-de Bos I; Van Tulder M; Boers M; Verhoeven AC; Adèr HJ; Bibo J; Boonen A; Van Der Linden S
J Rheumatol; 2004 Sep; 31(9):1709-16. PubMed ID: 15338488
[TBL] [Abstract][Full Text] [Related]
20. Costs of rheumatoid arthritis in France: a multicenter study of 1109 patients managed by hospital-based rheumatologists.
Guillemin F; Durieux S; Daurès JP; Lafuma A; Saraux A; Sibilia J; Bourgeois P; Sany J
J Rheumatol; 2004 Jul; 31(7):1297-304. PubMed ID: 15229947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
